Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z5HB
|
||||
Former ID |
DIB009972
|
||||
Drug Name |
FH-510
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Terminated | [545084] | ||
Company |
Taisho Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C22H31ClN2
|
||||
Canonical SMILES |
[nH]1c2c(c3c1cccc3CCN(CCC)CCC)c(ccc2C)C.Cl
|
||||
CAS Number |
CAS 139304-28-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sigma(1)-type opioid receptor | Target Info | Modulator | [526642], [532713], [533898] | |
References | |||||
Ref 526642 | Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats. Brain Res. 1992 Oct 30;594(2):323-6. | ||||
Ref 532713 | Antitussives and substance abuse. Subst Abuse Rehabil. 2013 Nov 6;4:75-82. | ||||
Ref 533898 | FH-510, a potent and selective ligand for rat brain sigma recognition sites. Eur J Pharmacol. 1993 Jul 6;238(1):89-92. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.